{"id":6460,"date":"2019-07-11T12:48:20","date_gmt":"2019-07-11T10:48:20","guid":{"rendered":"https:\/\/profertil.eu\/etudes\/etude-adn-2019\/"},"modified":"2023-09-26T13:52:26","modified_gmt":"2023-09-26T11:52:26","slug":"etude-adn-2019","status":"publish","type":"page","link":"https:\/\/profertil.eu\/fr\/etudes\/etude-adn-2019\/","title":{"rendered":"\u00c9tude ADN 2019"},"content":{"rendered":"\n
\"\"
\n

R\u00c9DUIT
LA FRAGMENTATION DE L\u2019ADN<\/span><\/h1>\n<\/div><\/div>\n\n\n\n
\n
<\/div>\n\n\n\n
\"\"<\/figure><\/div>\n\n\n\n

\u00bbR\u00e9duction significative de la fragmentation de l\u2019ADN dans le sperme\u00ab<\/p>\n\n\n\n

<\/div>\n<\/div><\/div>\n\n\n\n
\n
\n
\n
<\/div>\n\n\n\n

\u00c9TUDE ADN 2019<\/p>\n\n\n\n

R\u00e9duction de la fragmentation de l\u2019ADN des spermatozo\u00efdes (en%) apr\u00e8s 3 mois de prise de PROFERTIL\u00ae<\/sup><\/h3>\n<\/div>\n\n\n\n
\n
\"\"<\/figure><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure><\/div>\n<\/div>\n\n\n\n
\n
\"Aspire,<\/figure>\n\n\n\n
<\/div>\n\n\n\n

Nombre de patients: <\/strong>
<\/strong>n = 306
(groupe PROFERTIL\u00ae<\/sup>: n = 146;
groupe de contr\u00f4le: n = 160)

<\/p>\n\n\n\n

Presentation<\/strong>:
Aspire 2019, Hongkong;
publication en cours<\/p>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
La composition unique et brevet\u00e9e de PROFERTIL\u00ae<\/sup><\/strong><\/h6>\n\n\n\n